Can a mosquito-borne virus become a cancer therapy? rethinking Getah virus through the lens of oncolytic virotherapy.

Efa BB, Antwi-Osei Jnr J

Open source

DOI
10.3389/fcimb.2026.1768174
Published
2026
Container
Frontiers in cellular and infection microbiology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1768174,
  title = {Can a mosquito-borne virus become a cancer therapy? rethinking Getah virus through the lens of oncolytic virotherapy.},
  author = {Efa BB and Antwi-Osei Jnr J},
  year = {2026},
  journal = {Frontiers in cellular and infection microbiology},
  doi = {10.3389/fcimb.2026.1768174},
  url = {https://doi.org/10.3389/fcimb.2026.1768174}
}

RIS

TY  - JOUR
TI  - Can a mosquito-borne virus become a cancer therapy? rethinking Getah virus through the lens of oncolytic virotherapy.
AU  - Efa BB
AU  - Antwi-Osei Jnr J
PY  - 2026
JO  - Frontiers in cellular and infection microbiology
DO  - 10.3389/fcimb.2026.1768174
UR  - https://doi.org/10.3389/fcimb.2026.1768174
ER  - 

APA

BB, E., & J, A. J. (2026). Can a mosquito-borne virus become a cancer therapy? rethinking Getah virus through the lens of oncolytic virotherapy.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1768174

Source records